Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPRY domain-containing SOCS box protein 1 (SPSB1) is a protein encoded by the SPSB1 gene in humans. It serves as a substrate recognition component of an E3 ubiquitin-protein ligase complex, mediating the ubiquitination and subsequent proteasomal degradation of specific target proteins. SPSB1 is involved in the regulation of nitric oxide production by targeting inducible nitric oxide synthase (NOS2) in activated macrophages, thereby modulating immune responses and cellular toxicity. The gene is associated with pathways such as protein metabolism and MHC class I-mediated antigen processing[2][4][5][6][8]. SPSB1 does not currently have direct therapeutic targeting agents, and while it is not considered a classic therapeutic target (like an enzyme or receptor), disruptions in its function are linked to certain muscular dystrophies and possibly immunological or inflammatory processes[2].
Substrate recognition for E3 ubiquitin-protein ligase complexes (mediates ubiquitination and degradation of specific substrates, notably inducible nitric oxide synthase NOS2[2])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SPRY domain-containing SOCS box protein 1 (SPSB1).